candesartan has been researched along with indole-3-carbinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitchell, KD; Mullins, JJ | 1 |
| Baylis, C; Cunningham, MW; Milani, CJ; Mitchell, KD; Sasser, JM; West, CA | 1 |
2 other study(ies) available for candesartan and indole-3-carbinol
| Article | Year |
|---|---|
Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Benzimidazoles; Biphenyl Compounds; Cytochrome P-450 CYP1A1; Feedback; Glomerular Filtration Rate; Hypertension, Malignant; Indoles; Kidney Glomerulus; Kidney Tubules; Male; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Renal Circulation; Renin; Tetrazoles | 2005 |
Renal nitric oxide synthase and antioxidant preservation in Cyp1a1-Ren-2 transgenic rats with inducible malignant hypertension.
Topics: Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cytochrome P-450 CYP1A1; Glomerular Filtration Rate; Hypertension, Malignant; Indoles; Kidney; Male; NADPH Oxidases; Nitric Oxide Synthase Type I; Rats; Rats, Transgenic; Tetrazoles | 2013 |